In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products ...

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility Company reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash ...

The Washington State Department of Health has announced that H5N5, a bird flu strain that has never been detected in humans ...

Washington reports world's first fatal human H5N5 bird flu case; officials say risk to public remains low, monitoring ...

Schwab US Dividend Equity ETF ( $SCHD ) has risen by 0.37% in the past week. It has experienced a 5-day net outflow of $54.69 million. This is ...

The Marburg Virus Disease Therapeutics Market in the U.S. is projected to experience consistent growth from 2025 to 2035. With an estimated market size of USD 100.9 Million in 2025, the market is ...